Oncolytic Immunotherapies for Skin Cancer: Feasible and Practical Considerations

•Download as PPT, PDF•

0 likes•7 views

Michael K. Wong, MD, PhD, FRCPC discusses skin cancer in this CME activity titled "Oncolytic Immunotherapies for Skin Cancer: Feasible and Practical Considerations." For the full presentation, please visit us at www.peervoice.com/KJE870.

Health & Medicine

Oncolytic Immunotherapies for Skin Cancer: Feasible and Practical Considerations

Oncolytic Immunotherapies for Skin Cancer: Feasible and Practical Considerations

Oncolytic Immunotherapies for Skin Cancer: Feasible and Practical Considerations

Oncolytic Immunotherapies for Skin Cancer: Feasible and Practical Considerations

Oncolytic Immunotherapies for Skin Cancer: Feasible and Practical Considerations

Oncolytic Immunotherapies for Skin Cancer: Feasible and Practical Considerations

Oncolytic Immunotherapies for Skin Cancer: Feasible and Practical Considerations

Oncolytic Immunotherapies for Skin Cancer: Feasible and Practical Considerations

Oncolytic Immunotherapies for Skin Cancer: Feasible and Practical Considerations

Oncolytic Immunotherapies for Skin Cancer: Feasible and Practical Considerations

Oncolytic Immunotherapies for Skin Cancer: Feasible and Practical Considerations

Oncolytic Immunotherapies for Skin Cancer: Feasible and Practical Considerations

Oncolytic Immunotherapies for Skin Cancer: Feasible and Practical Considerations

Oncolytic Immunotherapies for Skin Cancer: Feasible and Practical Considerations

Oncolytic Immunotherapies for Skin Cancer: Feasible and Practical Considerations

Oncolytic Immunotherapies for Skin Cancer: Feasible and Practical Considerations

Oncolytic Immunotherapies for Skin Cancer: Feasible and Practical Considerations

Oncolytic Immunotherapies for Skin Cancer: Feasible and Practical Considerations

Oncolytic Immunotherapies for Skin Cancer: Feasible and Practical Considerations

Oncolytic Immunotherapies for Skin Cancer: Feasible and Practical Considerations

Oncolytic Immunotherapies for Skin Cancer: Feasible and Practical Considerations

Oncolytic Immunotherapies for Skin Cancer: Feasible and Practical Considerations

Oncolytic Immunotherapies for Skin Cancer: Feasible and Practical Considerations

Oncolytic Immunotherapies for Skin Cancer: Feasible and Practical Considerations

Oncolytic Immunotherapies for Skin Cancer: Feasible and Practical Considerations

Oncolytic Immunotherapies for Skin Cancer: Feasible and Practical Considerations

Oncolytic Immunotherapies for Skin Cancer: Feasible and Practical Considerations

Oncolytic Immunotherapies for Skin Cancer: Feasible and Practical Considerations

Recommended

Treating T2D in People of Younger Age in This Day and Age: How Would You Mana...

Treating T2D in People of Younger Age in This Day and Age: How Would You Mana...

Treating T2D in People of Younger Age in This Day and Age: How Would You Mana...PeerVoice

Optimising Outcomes for Our Patients With Advanced Urothelial Carcinoma: Best...

Optimising Outcomes for Our Patients With Advanced Urothelial Carcinoma: Best...

Optimising Outcomes for Our Patients With Advanced Urothelial Carcinoma: Best...PeerVoice

The Quest for Optimal Haemolytic Control of Paroxysmal Nocturnal Haemoglobinuria

The Quest for Optimal Haemolytic Control of Paroxysmal Nocturnal Haemoglobinuria

The Quest for Optimal Haemolytic Control of Paroxysmal Nocturnal HaemoglobinuriaPeerVoice

When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease o...

When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease o...

When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease o...PeerVoice

CGA - Identify and Intervene: Optimising Care Pathways for Chronic Kidney Dis...

CGA - Identify and Intervene: Optimising Care Pathways for Chronic Kidney Dis...

CGA - Identify and Intervene: Optimising Care Pathways for Chronic Kidney Dis...PeerVoice

Are You Forearmed When Managing Toxicities Associated With Chemoradiotherapy ...

Are You Forearmed When Managing Toxicities Associated With Chemoradiotherapy ...

Are You Forearmed When Managing Toxicities Associated With Chemoradiotherapy ...PeerVoice

Navigating Decisions With Limited Tools: A Review of Best Practices in Managi...

Navigating Decisions With Limited Tools: A Review of Best Practices in Managi...

Navigating Decisions With Limited Tools: A Review of Best Practices in Managi...PeerVoice

Neuroimmunology Matters: A Specific Review of Emerging Targeted Strategies fo...

Neuroimmunology Matters: A Specific Review of Emerging Targeted Strategies fo...

Neuroimmunology Matters: A Specific Review of Emerging Targeted Strategies fo...PeerVoice

Recommended

Treating T2D in People of Younger Age in This Day and Age: How Would You Mana...

Treating T2D in People of Younger Age in This Day and Age: How Would You Mana...

Treating T2D in People of Younger Age in This Day and Age: How Would You Mana...PeerVoice

Optimising Outcomes for Our Patients With Advanced Urothelial Carcinoma: Best...

Optimising Outcomes for Our Patients With Advanced Urothelial Carcinoma: Best...

Optimising Outcomes for Our Patients With Advanced Urothelial Carcinoma: Best...PeerVoice

The Quest for Optimal Haemolytic Control of Paroxysmal Nocturnal Haemoglobinuria

The Quest for Optimal Haemolytic Control of Paroxysmal Nocturnal Haemoglobinuria

The Quest for Optimal Haemolytic Control of Paroxysmal Nocturnal HaemoglobinuriaPeerVoice

When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease o...

When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease o...

When Blood Kills Babies: Identifying and Managing Severe Haemolytic Disease o...PeerVoice

CGA - Identify and Intervene: Optimising Care Pathways for Chronic Kidney Dis...

CGA - Identify and Intervene: Optimising Care Pathways for Chronic Kidney Dis...

CGA - Identify and Intervene: Optimising Care Pathways for Chronic Kidney Dis...PeerVoice

Are You Forearmed When Managing Toxicities Associated With Chemoradiotherapy ...

Are You Forearmed When Managing Toxicities Associated With Chemoradiotherapy ...

Are You Forearmed When Managing Toxicities Associated With Chemoradiotherapy ...PeerVoice

Navigating Decisions With Limited Tools: A Review of Best Practices in Managi...

Navigating Decisions With Limited Tools: A Review of Best Practices in Managi...

Navigating Decisions With Limited Tools: A Review of Best Practices in Managi...PeerVoice

Neuroimmunology Matters: A Specific Review of Emerging Targeted Strategies fo...

Neuroimmunology Matters: A Specific Review of Emerging Targeted Strategies fo...

Neuroimmunology Matters: A Specific Review of Emerging Targeted Strategies fo...PeerVoice

Don’t Forget About MET: Keys to Detecting and Targeting MET Alterations as a ...

Don’t Forget About MET: Keys to Detecting and Targeting MET Alterations as a ...

Don’t Forget About MET: Keys to Detecting and Targeting MET Alterations as a ...PeerVoice

Practical Perspectives and Straightforward Strategies for Optimising GDMT in ...

Practical Perspectives and Straightforward Strategies for Optimising GDMT in ...

Practical Perspectives and Straightforward Strategies for Optimising GDMT in ...PeerVoice

MDT Management of Patients Receiving Radioligand Therapy: Strategies to Optim...

MDT Management of Patients Receiving Radioligand Therapy: Strategies to Optim...

MDT Management of Patients Receiving Radioligand Therapy: Strategies to Optim...PeerVoice

Taking the Evidence from Paper to Practice: Shared Perspectives on Practical ...

Taking the Evidence from Paper to Practice: Shared Perspectives on Practical ...

Taking the Evidence from Paper to Practice: Shared Perspectives on Practical ...PeerVoice

Disruption at the Neuromuscular Junction: Relevance of Autoantibodies to Ther...

Disruption at the Neuromuscular Junction: Relevance of Autoantibodies to Ther...

Disruption at the Neuromuscular Junction: Relevance of Autoantibodies to Ther...PeerVoice

The Science and the Art of Sequencing Therapies in Advanced CRC Beyond the Se...

The Science and the Art of Sequencing Therapies in Advanced CRC Beyond the Se...

The Science and the Art of Sequencing Therapies in Advanced CRC Beyond the Se...PeerVoice

Expert Lines of Thought in Sequencing Later Lines of Therapy in Advanced CRC

Expert Lines of Thought in Sequencing Later Lines of Therapy in Advanced CRC

Expert Lines of Thought in Sequencing Later Lines of Therapy in Advanced CRCPeerVoice

The Case for Improved Care in COPD: Appreciating COPD as a Leading Cause of D...

The Case for Improved Care in COPD: Appreciating COPD as a Leading Cause of D...

The Case for Improved Care in COPD: Appreciating COPD as a Leading Cause of D...PeerVoice

TROP2-Directed Antibody-Drug Conjugates for Breast Cancer: The Clinical Signi...

TROP2-Directed Antibody-Drug Conjugates for Breast Cancer: The Clinical Signi...

TROP2-Directed Antibody-Drug Conjugates for Breast Cancer: The Clinical Signi...PeerVoice

Building a Better Approach to Obesity Care in Our Clinical Practices

Building a Better Approach to Obesity Care in Our Clinical Practices

Building a Better Approach to Obesity Care in Our Clinical PracticesPeerVoice

Catch Them Before They Fall: A Call to Action for Comprehensive Testing for H...

Catch Them Before They Fall: A Call to Action for Comprehensive Testing for H...

Catch Them Before They Fall: A Call to Action for Comprehensive Testing for H...PeerVoice

Radioligand Therapy and Therapeutic Sequencing in mCRPC

Radioligand Therapy and Therapeutic Sequencing in mCRPC

Radioligand Therapy and Therapeutic Sequencing in mCRPCPeerVoice

Multidisciplinary Perspectives on Advanced Management of CPF in CD: Exploring...

Multidisciplinary Perspectives on Advanced Management of CPF in CD: Exploring...

Multidisciplinary Perspectives on Advanced Management of CPF in CD: Exploring...PeerVoice

Approaching Airway Inflammation From Another Angle: The Rationale for Targeti...

Approaching Airway Inflammation From Another Angle: The Rationale for Targeti...

Approaching Airway Inflammation From Another Angle: The Rationale for Targeti...PeerVoice

What’s New and What’s Next? Expanding Our Understanding of HCM in 2023

What’s New and What’s Next? Expanding Our Understanding of HCM in 2023

What’s New and What’s Next? Expanding Our Understanding of HCM in 2023PeerVoice

Adjusting Our Mindset and Our Approach: Patient and Provider Perspectives on ...

Adjusting Our Mindset and Our Approach: Patient and Provider Perspectives on ...

Adjusting Our Mindset and Our Approach: Patient and Provider Perspectives on ...PeerVoice

Abundance of Choice at First Line, Lack of Options Beyond: Addressing Unmet N...

Abundance of Choice at First Line, Lack of Options Beyond: Addressing Unmet N...

Abundance of Choice at First Line, Lack of Options Beyond: Addressing Unmet N...PeerVoice

Overcoming Barriers to Better Care in CCA: Keys to Optimising Multidisciplina...

Overcoming Barriers to Better Care in CCA: Keys to Optimising Multidisciplina...

Overcoming Barriers to Better Care in CCA: Keys to Optimising Multidisciplina...PeerVoice

Radioligand Therapy for Prostate Cancer: Predicting Who May Benefit and Who M...

Radioligand Therapy for Prostate Cancer: Predicting Who May Benefit and Who M...

Radioligand Therapy for Prostate Cancer: Predicting Who May Benefit and Who M...PeerVoice

Key Updates on the Treatment Paradigm for Systemic Lupus Erythematosus

Key Updates on the Treatment Paradigm for Systemic Lupus Erythematosus

Key Updates on the Treatment Paradigm for Systemic Lupus ErythematosusPeerVoice

More Related Content

More from PeerVoice

Don’t Forget About MET: Keys to Detecting and Targeting MET Alterations as a ...

Don’t Forget About MET: Keys to Detecting and Targeting MET Alterations as a ...

Don’t Forget About MET: Keys to Detecting and Targeting MET Alterations as a ...PeerVoice

Practical Perspectives and Straightforward Strategies for Optimising GDMT in ...

Practical Perspectives and Straightforward Strategies for Optimising GDMT in ...

Practical Perspectives and Straightforward Strategies for Optimising GDMT in ...PeerVoice

MDT Management of Patients Receiving Radioligand Therapy: Strategies to Optim...

MDT Management of Patients Receiving Radioligand Therapy: Strategies to Optim...

MDT Management of Patients Receiving Radioligand Therapy: Strategies to Optim...PeerVoice

Taking the Evidence from Paper to Practice: Shared Perspectives on Practical ...

Taking the Evidence from Paper to Practice: Shared Perspectives on Practical ...

Taking the Evidence from Paper to Practice: Shared Perspectives on Practical ...PeerVoice

Disruption at the Neuromuscular Junction: Relevance of Autoantibodies to Ther...

Disruption at the Neuromuscular Junction: Relevance of Autoantibodies to Ther...

Disruption at the Neuromuscular Junction: Relevance of Autoantibodies to Ther...PeerVoice

The Science and the Art of Sequencing Therapies in Advanced CRC Beyond the Se...

The Science and the Art of Sequencing Therapies in Advanced CRC Beyond the Se...

The Science and the Art of Sequencing Therapies in Advanced CRC Beyond the Se...PeerVoice

Expert Lines of Thought in Sequencing Later Lines of Therapy in Advanced CRC

Expert Lines of Thought in Sequencing Later Lines of Therapy in Advanced CRC

Expert Lines of Thought in Sequencing Later Lines of Therapy in Advanced CRCPeerVoice

The Case for Improved Care in COPD: Appreciating COPD as a Leading Cause of D...

The Case for Improved Care in COPD: Appreciating COPD as a Leading Cause of D...

The Case for Improved Care in COPD: Appreciating COPD as a Leading Cause of D...PeerVoice

TROP2-Directed Antibody-Drug Conjugates for Breast Cancer: The Clinical Signi...

TROP2-Directed Antibody-Drug Conjugates for Breast Cancer: The Clinical Signi...

TROP2-Directed Antibody-Drug Conjugates for Breast Cancer: The Clinical Signi...PeerVoice

Building a Better Approach to Obesity Care in Our Clinical Practices

Building a Better Approach to Obesity Care in Our Clinical Practices

Building a Better Approach to Obesity Care in Our Clinical PracticesPeerVoice

Catch Them Before They Fall: A Call to Action for Comprehensive Testing for H...

Catch Them Before They Fall: A Call to Action for Comprehensive Testing for H...

Catch Them Before They Fall: A Call to Action for Comprehensive Testing for H...PeerVoice

Radioligand Therapy and Therapeutic Sequencing in mCRPC

Radioligand Therapy and Therapeutic Sequencing in mCRPC

Radioligand Therapy and Therapeutic Sequencing in mCRPCPeerVoice

Multidisciplinary Perspectives on Advanced Management of CPF in CD: Exploring...

Multidisciplinary Perspectives on Advanced Management of CPF in CD: Exploring...

Multidisciplinary Perspectives on Advanced Management of CPF in CD: Exploring...PeerVoice

Approaching Airway Inflammation From Another Angle: The Rationale for Targeti...

Approaching Airway Inflammation From Another Angle: The Rationale for Targeti...

Approaching Airway Inflammation From Another Angle: The Rationale for Targeti...PeerVoice

What’s New and What’s Next? Expanding Our Understanding of HCM in 2023

What’s New and What’s Next? Expanding Our Understanding of HCM in 2023

What’s New and What’s Next? Expanding Our Understanding of HCM in 2023PeerVoice

Adjusting Our Mindset and Our Approach: Patient and Provider Perspectives on ...

Adjusting Our Mindset and Our Approach: Patient and Provider Perspectives on ...

Adjusting Our Mindset and Our Approach: Patient and Provider Perspectives on ...PeerVoice

Abundance of Choice at First Line, Lack of Options Beyond: Addressing Unmet N...

Abundance of Choice at First Line, Lack of Options Beyond: Addressing Unmet N...

Abundance of Choice at First Line, Lack of Options Beyond: Addressing Unmet N...PeerVoice

Overcoming Barriers to Better Care in CCA: Keys to Optimising Multidisciplina...

Overcoming Barriers to Better Care in CCA: Keys to Optimising Multidisciplina...

Overcoming Barriers to Better Care in CCA: Keys to Optimising Multidisciplina...PeerVoice

Radioligand Therapy for Prostate Cancer: Predicting Who May Benefit and Who M...

Radioligand Therapy for Prostate Cancer: Predicting Who May Benefit and Who M...

Radioligand Therapy for Prostate Cancer: Predicting Who May Benefit and Who M...PeerVoice

Key Updates on the Treatment Paradigm for Systemic Lupus Erythematosus

Key Updates on the Treatment Paradigm for Systemic Lupus Erythematosus

Key Updates on the Treatment Paradigm for Systemic Lupus ErythematosusPeerVoice

More from PeerVoice (20)

Don’t Forget About MET: Keys to Detecting and Targeting MET Alterations as a ...

Don’t Forget About MET: Keys to Detecting and Targeting MET Alterations as a ...

Don’t Forget About MET: Keys to Detecting and Targeting MET Alterations as a ...

Practical Perspectives and Straightforward Strategies for Optimising GDMT in ...

Practical Perspectives and Straightforward Strategies for Optimising GDMT in ...

Practical Perspectives and Straightforward Strategies for Optimising GDMT in ...

MDT Management of Patients Receiving Radioligand Therapy: Strategies to Optim...

MDT Management of Patients Receiving Radioligand Therapy: Strategies to Optim...

MDT Management of Patients Receiving Radioligand Therapy: Strategies to Optim...

Taking the Evidence from Paper to Practice: Shared Perspectives on Practical ...

Taking the Evidence from Paper to Practice: Shared Perspectives on Practical ...

Taking the Evidence from Paper to Practice: Shared Perspectives on Practical ...

Disruption at the Neuromuscular Junction: Relevance of Autoantibodies to Ther...

Disruption at the Neuromuscular Junction: Relevance of Autoantibodies to Ther...

Disruption at the Neuromuscular Junction: Relevance of Autoantibodies to Ther...

The Science and the Art of Sequencing Therapies in Advanced CRC Beyond the Se...

The Science and the Art of Sequencing Therapies in Advanced CRC Beyond the Se...

The Science and the Art of Sequencing Therapies in Advanced CRC Beyond the Se...

Expert Lines of Thought in Sequencing Later Lines of Therapy in Advanced CRC

Expert Lines of Thought in Sequencing Later Lines of Therapy in Advanced CRC

Expert Lines of Thought in Sequencing Later Lines of Therapy in Advanced CRC

The Case for Improved Care in COPD: Appreciating COPD as a Leading Cause of D...

The Case for Improved Care in COPD: Appreciating COPD as a Leading Cause of D...

The Case for Improved Care in COPD: Appreciating COPD as a Leading Cause of D...

TROP2-Directed Antibody-Drug Conjugates for Breast Cancer: The Clinical Signi...

TROP2-Directed Antibody-Drug Conjugates for Breast Cancer: The Clinical Signi...

TROP2-Directed Antibody-Drug Conjugates for Breast Cancer: The Clinical Signi...

Building a Better Approach to Obesity Care in Our Clinical Practices

Building a Better Approach to Obesity Care in Our Clinical Practices

Building a Better Approach to Obesity Care in Our Clinical Practices

Catch Them Before They Fall: A Call to Action for Comprehensive Testing for H...

Catch Them Before They Fall: A Call to Action for Comprehensive Testing for H...

Catch Them Before They Fall: A Call to Action for Comprehensive Testing for H...

Radioligand Therapy and Therapeutic Sequencing in mCRPC

Radioligand Therapy and Therapeutic Sequencing in mCRPC

Radioligand Therapy and Therapeutic Sequencing in mCRPC

Multidisciplinary Perspectives on Advanced Management of CPF in CD: Exploring...

Multidisciplinary Perspectives on Advanced Management of CPF in CD: Exploring...

Multidisciplinary Perspectives on Advanced Management of CPF in CD: Exploring...

Approaching Airway Inflammation From Another Angle: The Rationale for Targeti...

Approaching Airway Inflammation From Another Angle: The Rationale for Targeti...

Approaching Airway Inflammation From Another Angle: The Rationale for Targeti...

What’s New and What’s Next? Expanding Our Understanding of HCM in 2023

What’s New and What’s Next? Expanding Our Understanding of HCM in 2023

What’s New and What’s Next? Expanding Our Understanding of HCM in 2023

Adjusting Our Mindset and Our Approach: Patient and Provider Perspectives on ...

Adjusting Our Mindset and Our Approach: Patient and Provider Perspectives on ...

Adjusting Our Mindset and Our Approach: Patient and Provider Perspectives on ...

Abundance of Choice at First Line, Lack of Options Beyond: Addressing Unmet N...

Abundance of Choice at First Line, Lack of Options Beyond: Addressing Unmet N...

Abundance of Choice at First Line, Lack of Options Beyond: Addressing Unmet N...

Overcoming Barriers to Better Care in CCA: Keys to Optimising Multidisciplina...

Overcoming Barriers to Better Care in CCA: Keys to Optimising Multidisciplina...

Overcoming Barriers to Better Care in CCA: Keys to Optimising Multidisciplina...

Radioligand Therapy for Prostate Cancer: Predicting Who May Benefit and Who M...

Radioligand Therapy for Prostate Cancer: Predicting Who May Benefit and Who M...

Radioligand Therapy for Prostate Cancer: Predicting Who May Benefit and Who M...

Key Updates on the Treatment Paradigm for Systemic Lupus Erythematosus

Key Updates on the Treatment Paradigm for Systemic Lupus Erythematosus

Key Updates on the Treatment Paradigm for Systemic Lupus Erythematosus